299 related articles for article (PubMed ID: 33775895)
1. Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.
Graham DY; Liou JM
Clin Gastroenterol Hepatol; 2022 May; 20(5):973-983.e1. PubMed ID: 33775895
[TBL] [Abstract][Full Text] [Related]
2. Transitioning of
Graham DY
Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33023041
[No Abstract] [Full Text] [Related]
3. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
Graham DY; Dore MP; Lu H
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):679-687. PubMed ID: 30102559
[TBL] [Abstract][Full Text] [Related]
4. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
Graham DY; Lu H; Shiotani A
J Gastroenterol Hepatol; 2021 May; 36(5):1159-1163. PubMed ID: 32918832
[TBL] [Abstract][Full Text] [Related]
5. How widespread and convenient
Rokkas T; Graham DY
Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):1-7. PubMed ID: 36594260
[TBL] [Abstract][Full Text] [Related]
6.
Shiotani A; Roy P; Lu H; Graham DY
Therap Adv Gastroenterol; 2021; 14():17562848211064080. PubMed ID: 34987609
[TBL] [Abstract][Full Text] [Related]
7. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
Graham DY; Lu H; Yamaoka Y
Drugs; 2008; 68(6):725-36. PubMed ID: 18416582
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Treatment of
Lee YC; Dore MP; Graham DY
Annu Rev Med; 2022 Jan; 73():183-195. PubMed ID: 35084993
[TBL] [Abstract][Full Text] [Related]
9. Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis.
Rokkas T; Ekmektzoglou K; Graham DY
Helicobacter; 2023 Feb; 28(1):e12936. PubMed ID: 36458328
[TBL] [Abstract][Full Text] [Related]
10. Cross-roads for meta-analysis and network meta-analysis of
Graham DY; Hernaez R; Rokkas T
Gut; 2022 Mar; 71(3):643-650. PubMed ID: 34750206
[No Abstract] [Full Text] [Related]
11. Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.
Shiotani A; Lu H; Dore MP; Graham DY
Cleve Clin J Med; 2017 Apr; 84(4):310-318. PubMed ID: 28388387
[TBL] [Abstract][Full Text] [Related]
12. Efficient identification and evaluation of effective Helicobacter pylori therapies.
Graham DY
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):145-8. PubMed ID: 19026766
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
Ortiz V; Estevez-Ordonez D; Montalvan-Sanchez E; Urrutia-Argueta S; Israel D; Krishna US; Romero-Gallo J; Wilson KT; Peek RM; Dominguez R; Morgan DR
Helicobacter; 2019 Aug; 24(4):e12595. PubMed ID: 31111610
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Treatment of Helicobacter pylori Infections.
Matsumoto H; Shiotani A; Graham DY
Adv Exp Med Biol; 2019; 1149():211-225. PubMed ID: 31016626
[TBL] [Abstract][Full Text] [Related]
16. Current treatment of Helicobacter pylori infection.
Gisbert JP; Molina-Infante J
Med Clin (Barc); 2017 Jan; 148(1):20-22. PubMed ID: 27916266
[No Abstract] [Full Text] [Related]
17. Importance of antimicrobial susceptibility testing for the management of eradication in
Arslan N; Yılmaz Ö; Demiray-Gürbüz E
World J Gastroenterol; 2017 Apr; 23(16):2854-2869. PubMed ID: 28522904
[TBL] [Abstract][Full Text] [Related]
18. Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy.
Graham DY; Megraud F
Helicobacter; 2021 Feb; 26(1):e12773. PubMed ID: 33207391
[No Abstract] [Full Text] [Related]
19. Screening and eradication of
Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
[TBL] [Abstract][Full Text] [Related]
20. Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
Kotilea K; Mekhael J; Salame A; Mahler T; Miendje-Deyi VY; Cadranel S; Bontems P
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28303625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
